Open AccessUse of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
Author(s) -
Graham C. Wong,
Robert P. Giugliano,
Elliott M. Antman
Publication year - 2003
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.289.3.331
Subject(s) - medicine , percutaneous coronary intervention , unstable angina , heparin , myocardial infarction , conventional pci , low molecular weight heparin , cardiology , antithrombotic , acute coronary syndrome , angina , angioplasty , clinical trial , intensive care medicine
Low-molecular-weight heparins (LMWHs) possess several potential pharmacological advantages over unfractionated heparin as an antithrombotic agent.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom